Mowad-Nassar Nicole 4
4 · RESMED INC · Filed Nov 26, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Mowad-Nassar Nicole
Director
Transactions
- Award
ResMed Common Stock Options
2025-11-24$250.52/sh+1,331$333,442→ 1,331 totalExercise: $250.52From: 2026-11-11Exp: 2032-11-11→ ResMed Common Stock (1,331 underlying)
Holdings
- 777
ResMed Common Stock
Footnotes (1)
- [F1]Represents the date on which options first become exercisable. The options vest on the earlier of (i) November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date.